Achieve Life Sciences, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 5.48 million compared to USD 11.23 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.83 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.835 USD | +4.88% | +5.69% | +17.23% |
03:10pm | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
May. 09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.23% | 158M | |
+26.17% | 44.96B | |
-0.80% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.51% | 26.08B | |
-21.48% | 19.03B | |
+6.16% | 12.75B | |
+27.77% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Achieve Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023